25 November 2017
News and Views
Links and Services
The latest issue of Alimentary Pharmacology & Therapeutics investigates the loss of response to anti-tumor necrosis factor treatments in Crohn’s disease.
Loss of response to anti-TNF agents in Crohn’s disease is an emerging clinical problem.
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors